Mechanism of Action: Cholinergic Muscarinic Agonists
✉ Email this page to a colleague
Drugs with Mechanism of Action: Cholinergic Muscarinic Agonists
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | VUITY | pilocarpine hydrochloride | SOLUTION;OPHTHALMIC | 214028-001 | Oct 28, 2021 | RX | Yes | Yes | 11,285,134 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Abbvie | VUITY | pilocarpine hydrochloride | SOLUTION;OPHTHALMIC | 214028-001 | Oct 28, 2021 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Abbvie | VUITY | pilocarpine hydrochloride | SOLUTION;OPHTHALMIC | 214028-001 | Oct 28, 2021 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Abbvie | VUITY | pilocarpine hydrochloride | SOLUTION;OPHTHALMIC | 214028-001 | Oct 28, 2021 | RX | Yes | Yes | 10,610,518 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Concordia | SALAGEN | pilocarpine hydrochloride | TABLET;ORAL | 020237-001 | Mar 22, 1994 | AB | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Concordia | SALAGEN | pilocarpine hydrochloride | TABLET;ORAL | 020237-002 | Apr 18, 2003 | AB | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Orasis Pharms | QLOSI | pilocarpine hydrochloride | SOLUTION;OPHTHALMIC | 217836-001 | Oct 17, 2023 | RX | Yes | Yes | 9,867,810 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
